Over the years, Sachdeva has identified new molecular pathways and mechanisms for therapeutic agents intended for the treatment of lung cancer and skin inflammation. Additionally, he has made significant contributions in understanding skin irritation markers in the skin.
“This is not only a great honor for me, but also for Florida A&M, which gave me a platform to strive for excellence in research by caring for the students,” said Sachdeva. “This clearly demonstrates that high quality pharmaceutical research is being conducted here at Florida A&M, which is being recognized by my peers across the country.”
“I join our many colleagues in the pharmaceutical sciences in congratulating
Sachdeva on receiving this national recognition,” said Henry Lewis, III dean of the College of Pharmacy and Pharmaceutical Sciences. “Sachdeva has been a significant contributor to research that enhances our abilities to treat several diseases.”
The American Association of Pharmaceutical Scientists (AAPS) publishes papers on innovative research spanning the entire spectrum of science that is the foundation of drug discovery, development, evaluation and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines and genetically engineered cells are an integral part of papers published in Pharmaceutical Research, the association’s principle research journal.